EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues
Gain Therapeutics, Inc. (GANX) EBITDA Margin data is not available.
| Income Statement Financials | |
-- |
|
$-4.54M |
|
-- |
|
-- |
|
$4.47M |
|
$-4.47M |
|
$-0.00M |
|
$-4.47M |
|
$-4.47M |
|
$-4.54M |
|
$-4.54M |
|
$-4.54M |
|
$-4.54M |
|
$-4.47M |
|
$-4.44M |
|
32.97M |
|
32.97M |
|
$-0.11 |
|
$-0.11 |
|
| Balance Sheet Financials | |
$22.24M |
|
$0.07M |
|
$0.58M |
|
$22.82M |
|
$3.35M |
|
$0.30M |
|
$0.90M |
|
$4.25M |
|
$18.56M |
|
$18.56M |
|
$18.56M |
|
42.07M |
|
| Cash Flow Statement Financials | |
$-18.47M |
|
-- |
|
$28.45M |
|
$10.42M |
|
$20.87M |
|
$10.46M |
|
$1.80M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.63 |
|
-- |
|
-- |
|
0.02 |
|
0.02 |
|
-- |
|
-- |
|
-- |
|
|
EBITDA Margin |
-- |
-- |
|
-- |
|
$-18.47M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-24.44% |
|
-24.44% |
|
-19.89% |
|
-24.05% |
|
$0.44 |
|
$-0.56 |
|
$-0.56 |
|